CVS(CVS)
CVS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $411.64B | $427.30B | $448.63B | $478.50B | $498.69B |
| Low | $410.31B | $417.76B | $416.26B | $465.76B | $485.41B |
| High | $413.23B | $441.25B | $473.10B | $494.12B | $514.97B |
| EBITDA Avg | $17.32B | $17.98B | $18.88B | $20.13B | $20.98B |
| Low | $17.26B | $17.58B | $17.51B | $19.60B | $20.42B |
| High | $17.39B | $18.57B | $19.91B | $20.79B | $21.67B |
| EBIT Avg | $12.01B | $12.47B | $13.09B | $13.97B | $14.55B |
| Low | $11.98B | $12.19B | $12.15B | $13.59B | $14.17B |
| High | $12.06B | $12.88B | $13.81B | $14.42B | $15.03B |
| Net Income Avg | $9.77B | $10.81B | $12.22B | $13.95B | $15.50B |
| Low | $9.58B | $10.50B | $11.41B | $13.47B | $14.97B |
| High | $9.97B | $11.21B | $12.87B | $14.54B | $16.16B |
| EPS Avg | $7.65 | $8.46 | $9.70 | $10.98 | $12.20 |
| Low | $7.54 | $8.26 | $8.98 | $10.60 | $11.77 |
| High | $7.85 | $8.82 | $10.13 | $11.44 | $12.71 |
| Analysts (Rev / EPS) | 10 / 16 | 17 / 17 | 15 / 11 | 10 / 4 | 7 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $103.64B | $106.11B | $103.49B | $105.39B | $107.71B | $110.54B | $109.45B | $110.53B |
| Low | $101.80B | $104.97B | $101.53B | $103.40B | $105.67B | $108.45B | $107.38B | $108.44B |
| High | $106.08B | $107.05B | $106.52B | $108.47B | $110.85B | $113.78B | $112.65B | $113.76B |
| EBITDA Avg | $4.36B | $4.46B | $4.35B | $4.43B | $4.53B | $4.65B | $4.61B | $4.65B |
| Low | $4.28B | $4.42B | $4.27B | $4.35B | $4.45B | $4.56B | $4.52B | $4.56B |
| High | $4.46B | $4.50B | $4.48B | $4.56B | $4.66B | $4.79B | $4.74B | $4.79B |
| EBIT Avg | $3.02B | $3.10B | $3.02B | $3.08B | $3.14B | $3.23B | $3.19B | $3.23B |
| Low | $2.97B | $3.06B | $2.96B | $3.02B | $3.08B | $3.17B | $3.13B | $3.16B |
| High | $3.10B | $3.12B | $3.11B | $3.17B | $3.24B | $3.32B | $3.29B | $3.32B |
| Net Income Avg | $2.15B | $1.69B | $3.56B | $2.89B | $2.49B | $1.95B | $4.09B | $3.24B |
| Low | $1.95B | $1.45B | $3.47B | $2.82B | $2.43B | $1.90B | $3.99B | $3.16B |
| High | $2.28B | $1.97B | $3.70B | $3.00B | $2.59B | $2.02B | $4.24B | $3.36B |
| EPS Avg | $1.68 | $1.32 | $2.78 | $2.25 | $1.94 | $1.52 | $3.19 | $2.53 |
| Low | $1.52 | $1.13 | $2.71 | $2.20 | $1.90 | $1.48 | $3.11 | $2.46 |
| High | $1.77 | $1.53 | $2.88 | $2.34 | $2.02 | $1.57 | $3.31 | $2.62 |
| Analysts (Rev / EPS) | 10 / 15 | 10 / 14 | 9 / 8 | 9 / 6 | 9 / 6 | 9 / 12 | 8 / 13 | 8 / 7 |